Vimarsana
Biggest News Aggregation in the World

Page 5 - Nasdaq Coll News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Coll. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Coll Today - Breaking & Trending Today

Gladius Capital Management LP Sells 478 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Vimarsana News

Gladius Capital Management LP Sells 478 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Gladius Capital Management LP cut its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 27.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,235 shares of the specialty pharmaceutical company’s stock after selling 478 shares during the […]

Collegium Pharmaceutical's (COLL) Neutral Rating Reiterated at HC Wainwright - Vimarsana News

Collegium Pharmaceutical's (COLL) Neutral Rating Reiterated at HC Wainwright

HC Wainwright reissued their neutral rating on shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) in a report issued on Friday morning, Benzinga reports. Several other analysts have also commented on COLL. Needham & Company LLC reaffirmed a buy rating and set a $35.00 price target on shares of Collegium Pharmaceutical in a research report […]

Collegium Pharmaceutical (NASDAQ:COLL) Trading Up 4.9% - Vimarsana News

Collegium Pharmaceutical (NASDAQ:COLL) Trading Up 4.9%

Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report)’s share price was up 4.9% during trading on Monday . The stock traded as high as $25.02 and last traded at $24.64. Approximately 108,557 shares traded hands during trading, a decline of 73% from the average daily volume of 396,780 shares. The stock had previously closed at […]

Source: wkrb13.com
30,388 Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Purchased by ProVise Management Group LLC - Vimarsana News

30,388 Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Purchased by ProVise Management Group LLC

ProVise Management Group LLC purchased a new stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 30,388 shares of the specialty pharmaceutical company’s stock, valued at approximately $729,000. ProVise Management Group LLC owned about 0.09% of […]

Collegium Pharmaceutical (NASDAQ:COLL) Raised to "Buy" at StockNews.com - Vimarsana News

Collegium Pharmaceutical (NASDAQ:COLL) Raised to "Buy" at StockNews.com

StockNews.com upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a hold rating to a buy rating in a report released on Wednesday. Several other equities analysts have also commented on COLL. Piper Sandler lowered their target price on Collegium Pharmaceutical from $37.00 to $35.00 in a report on Tuesday, April 25th. Needham & […]